Wall Street Cheers Lilly's $8 Billion Loxo Deal for Cancer Drugs

(Bloomberg) -- Wall Street got another pleasant surprise on Monday morning, with Eli Lilly & Co. agreeing to buy Loxo Oncology Inc. for about $8 billion in cash. Most analysts applauded the deal, s...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.